In conclusion, clinical trials reporting basal insulin titration in hitherto insulin-naïve patients with type 2 diabetes indicate better glycemic results (fasting plasma glucose and HbA1c at the end of the study) with more ambitious fasting plasma glucose titration targets, without showing associated risks or worse results in terms of safety consequences (hypoglycemia and weight gain). Here, INS is linked to Hypoglycemia.